David Eric Strauss

Insider Reports History

Location: Houston, TX
Signature: /s/ David Strauss
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Eric Strauss:

Form 4 holding Principal Accounting Officer

Terns Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 89,673
Estimated value: $519,682
Report date: 01 Feb 2025
Price: $5.80
Ownership: Direct

Insider Reports Filed by David Eric Strauss

3 TERN

Terns Pharmaceuticals, Inc.

Report period: 01 Feb 2025
Transactions: 0
Transaction value: $0
Filing time: 11 Feb 2025, 18:06
Role: Principal Accounting Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .